In addition to the amplitude of their specific T repertoires, Melan-A and MELOE-1 antigens were also selected on the basis of their frequent and shared expression by melanoma tumors, and regarding MELOE-1 antigen, for its strict tumor specificity. The gene discussed is MLANA; the disease is melanoma.